Latest news about Source Natural Foods
Source Natural Foods
110.05
0.00(0.00%)
Company Performance:
View Company Insights1D0.00%
1M-1.12%
6M-19.08%
1Y-20.83%
5Y-37.91%
More news about Source Natural Foods
06Mar 26
Source Natural Foods Transfers Solar Project to Subsidiary and Incorporates New WOS for Green Energy Expansion
Source Natural Foods and Herbal Supplements Limited approved the transfer of its 2 MW solar project in Odisha to wholly owned subsidiary Source Natural Solar Private Limited and the incorporation of a new subsidiary in Karnataka during its March 6, 2026 board meeting. The company has successfully commissioned a 0.5 MW rooftop solar project in Bangalore and secured 140 projects under PM Surya Ghar Yojana in recent months. The strategic moves support the company's renewable energy expansion through dedicated SPVs for efficient project management and operations.
14Feb 26
Source Natural Foods Reports Q3FY26 Results and Approves Green Energy Investments
Source Natural Foods announced Q3FY26 financial results showing total revenue of ₹2164.41 lakhs and EBITDA of ₹152.90 lakhs. The Ayurveda segment contributed ₹1461.23 lakhs while the Energy segment generated ₹703.18 lakhs. The board approved strategic investments of up to ₹10 crore each for subsidiary loans and equity capital in green energy projects.
11Feb 26
Source Natural Foods Incorporates Wholly-Owned Solar Subsidiary for Power Generation
Source Natural Foods and Herbal Supplements Limited has incorporated Source Natural Solar Private Limited as a wholly-owned subsidiary on February 06, 2026. The subsidiary has an authorized capital of Rs. 10,00,000 and paid-up capital of Rs. 1,00,000, with the parent company holding 100% shareholding through cash investment. The new entity will focus on developing and operating grid-connected Solar PV power projects, marking the company's strategic expansion into renewable energy sector.
13Aug 25
Source Natural Foods Approves Q1 Results, Appoints New Managing Director
Source Natural Foods and Herbal Supplements Limited announced key corporate developments following its board meeting on August 13, 2025. The board approved unaudited Q1 financial results ending June 30, 2025. Mr. Arvind Varchaswi was appointed as the new Managing Director for a five-year term, subject to shareholder approval. The board recommended the reappointment of Mr. Narayanan Narasimhan as Non-Executive Director and Chairperson. New appointments include M/s. KKR & Associates as Secretarial Auditor and M/s. Chiranjeevulu Jeelaga & Co. as Cost Auditors. The board also reviewed internal audit reports, related party transactions, and compliance statements.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Zydus Life Science
Cipla
Lupin
Mankind Pharma
Dr Reddys Laboratories
Laurus Labs
Aurobindo Pharma
1,944.00
(+0.10%)
8,600.00
(+0.25%)
4,893.00
(+0.14%)
1,205.00
(+1.18%)
1,463.00
(0.0%)
2,281.00
(+0.09%)
2,433.10
(+0.33%)
1,200.00
(-0.41%)
1,850.00
(-0.43%)
1,667.00
(+0.54%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
